Horizon scanning in oncology
Project leaders: Nicole Grössmann
Duration: since Oktober 2008
The establishment of a Horizon Scanning System for anticancer drugs is an important tool to prepare Austrian hospitals for new/ emerging medicines. After a first concept was developed and tested (July 2007 and May 2008) our project "Horizon Scanning in Oncology” was implemented as a routine programme at the LBI-HTA with the aim of facilitating the evidence-based use of anticancer therapies and of pre-estimating their potential financial implications in order to better inform decision-makers before the routine introduction of anti-cancer drugs into clinical practice. Since 2009, new oncologic drugs are regularly identified, prioritised and assessed and the final assessments are disseminated.
Maintenance of the programme as standard practice at the LBI-HTA by regular scanning of information sources, 3-monthly prioritization rounds, quarterly compilation of assessments on relevant oncologic drugs and dissemination of the reports.
• regular and systematic scanning of selected information sources including detailed/extended data extraction
• regular filtration and prioritisation by an interdisciplinary team of experts
• analysis of prioritisation results
• “early assessments” (1-3) on relevant drugs
• dissemination of reports